Science & Enterprise subscription

Follow us on Twitter

  • While much attention is focused on the current measles outbreak, distrust of vaccines apparently goes beyond this o… https://t.co/s8NjCmuLcN
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Where Vaccine Distrust is Greatest https://t.co/kfz5CxDZ9S #Science #Business
    about 2 days ago
  • New contributed post on Science and Enterprise: Making A Food Product That Promotes Cell Life https://t.co/QNdYrkTXbJ
    about 2 days ago
  • A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver… https://t.co/8BYvg8HiOD
    about 3 days ago
  • Why thank you @Annette_Welch ... It's a busy day, but what else is new. Enjoy your weekend. https://t.co/TUcnRWbOmD
    about 3 days ago

Please share Science & Enterprise

Pfizer to Build Research Labs in Cambridge, Mass.

Central Square subway station, Cambridge, Mass.  (Bart Howard Everts/Flickr)

Central Square subway station, Cambridge, Mass.

Pfizer Inc., the global pharmaceutical company based in New York, says it will build a new research facility in Cambridge, Massachusetts. The company expects the facility will employ a staff of 400, most in research or related positions.

The new building will be located in Kendall Square, just north of the MIT campus. Pfizer says it agreed to a 10-year lease on 180,000 square feet of space on that site. The company expects to move into the site in the fourth quarter of 2013.

The new facility will house Pfizer’s Cardiovascular, Metabolic and Endocrine Disease (CVMED) and Neuroscience research units. The relocation of the two operations will make it the second largest biopharmaceutical company in Massachusetts in terms of jobs. The work done at the new Cambridge site will involve biologists and chemists, as well as researchers from other disciplines.

This is Pfizer’s second expansion in Massachusetts this year. in June, the company announced the addition of eight research institutions in the state to its Centers for Therapeutic Innovation. Pfizer also plans to locate the translational network’s headquarters in Boston.

Read More: Pfizer Adds Mass. Institutions to Translational Network

Photo: Bart Howard Everts/Flickr

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.